|
[ISET]
肾去交感神经支配术:有所作为的重大机会
日期:2012-03-22 10:18:54
点击:203
一月在美国迈阿密 ISET( The International Symposium on Endovascular Therapy ) 会议上, 德国法兰克福心血管中心的Horst Sievert 告诉他的听众,为什么他认为肾去神经支配术和经皮冠状动脉介入或经皮血管成形术一样重要。我认为肾去神经支配术对于介入医生...
[快讯]
2012年3月介入快讯
日期:2012-03-19 22:03:10
点击:180
First US peripheral artery disease patient enrolled in CONNECT II trial Tuesday, 13 Mar 2012 09:43 Ocelot Avinger has announced the enrolment of the first US patient in the multicentre, non-randomised CONNECT II global clinical trial desig...
[SIR 2012]
关注 SIR 2012
日期:2012-03-02 23:57:50
点击:200
SIR 将在本次会议强调微创医学的进步和新的发现,可能改变现代医学许多种疾病的治疗方法。 预计超过5000名医生、科研人员和有关的卫生专业人员被期待参加这次重要介入放射学会议。这次会议的主题是介入放射学的证据,将反映SIR致力于该领域增长和发展,并证...
[CIRSE]
关注 CIRSE 2012
日期:2012-02-12 23:36:31
点击:172
With more than 6,100 participants, the CIRSE annual meeting is the largest and most comprehensive forum for experts in image-guided minimally invasive therapies. The CIRSE Annual Congress and Postgraduate Course isa trend-setting, dynamic...
[会讯]
ECIO 2012(意大利 佛罗伦萨)
日期:2012-02-12 00:01:28
点击:148
ECIO 2012 News Dont miss the deadline Our Early Bird registration deadline will only be available until February 16, 2012: Dont miss the chance to save to up 15% on the registration fee! REGISTER NOW! Accommodation The CIRSE Travel Service...
[快讯]
2012年1月介入快讯
日期:2012-01-25 11:49:41
点击:167
Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...
[快讯]
2012年1月介入快讯
日期:2012-01-25 11:49:41
点击:127
Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...
[快讯]
2012年1月介入快讯
日期:2012-01-25 11:49:41
点击:152
Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...
[快讯]
11月介入快讯
日期:2011-12-10 15:43:14
点击:184
拜耳介入专家委员会在三亚召开 一年一度的拜耳介入专家委员会近日在三亚召开。与会的数十名来自全国的介入放射学领域的专家就下列议题进行了热烈的讨论。 (1)TACE联合索拉菲尼治疗肝癌的研究进展(中山大学附属第一医院 杨建勇) (2)肝癌治疗现状中国与...
[快讯]
7月介入快讯
日期:2011-07-18 21:41:46
点击:177
Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib. Long-Term Outcome of Transcatheter Subsegmental and Segmental Arterial Chemoemobolization Using Lipiodol for Hepatocellular Carcinoma . Percutane...
会议概况 国际介入放射学并发症会议(ICCIR) 是专注于介入放射学(Interventional Ra...
以下是关于国际介入放射学并发症会议(ICCIR)的历史背景与发展脉络的梳理。由于公开...
中国首家AI医院,一个里程碑事件 环球时报 2025-05-17 08:50 北京 美国《每日银河》杂...
中国首家AI医院,一个里程碑事件 环球时报 2025-05-17 08:50 北京 美国《每日银河》杂...
结果显示中高危PE患者的管理发生了变化 在STRIKE-PE试验的期中亚组分析中,Andrew Sha...
最近发表在《柳叶刀肿瘤学》(The Lancet Oncology)上的一项随机、国际、多中心、III...